Purulent pleurisy caused by Campylobacter lari

被引：8

作者：

Bruneau, B

Burc, L

Bizet, C

Lambert-Zechovsky, N

Branger, C

机构：

[1] Hop Beaujon, Microbiol Serv, F-92118 Clichy, France

[2] Inst Pasteur, Collect Bacteries, F-75724 Paris 15, France

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1998年 / 17卷 / 03期

关键词：

Campylobacter lari; pleurisy; antibiotic therapy;

D O I：

10.1007/BF01691115

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

An 80-year-old debilitated patient developed purulent pleurisy caused by a Campylobacter lari isolate. The patient underwent surgical drainage and received antibiotic therapy with amoxicillin/clavulanic acid and ofloxacin. Antibiotic susceptibility data showed that the isolate was fully sensitive to clarithromycin, tetracycline, aminoglycosides, and ciprofloxacin. Imipenem and amoxicillin plus clavulanic acid were the most active beta-lactam agents.

引用

收藏

页码：185 / 188

页数：4

相关论文

共 19 条

[1]

*ANT COMM FRENCH S, 1996, 1996 STAT PATH BIOL, V44, pR1

[2] DESCRIPTION OF CAMPYLOBACTER-LARIDIS, A NEW SPECIES COMPRISING THE NALIDIXIC-ACID RESISTANT THERMOPHILIC CAMPYLOBACTER (NARTC) GROUP [J].

BENJAMIN, J ;

LEAPER, S ;

OWEN, RJ ;

SKIRROW, MB .

CURRENT MICROBIOLOGY, 1983, 8 (04) :231-238

[3] CHRONIC DIARRHEA AND BACTEREMIA CAUSED BY CAMPYLOBACTER-LARI IN A NEONATE [J].

CHIU, CH ;

KUO, CY ;

OU, JT .

CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) :700-701

[4] Genotypic diversity of Campylobacter lari isolated from mussels and oysters in The Netherlands [J].

Endtz, HP ;

Vliegenthart, JS ;

Vandamme, P ;

Weverink, HW ;

vandenBraak, NP ;

Verbrugh, HA ;

vanBelkum, A .

INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1997, 34 (01) :79-88

[5] CAMPYLOBACTER-LARIDIS COLITIS IN A HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENT TREATED WITH A QUINOLONE [J].

EVANS, TG ;

RILEY, D .

CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :172-173

[6] REACTIVE ARTHRITIS AS A COMPLICATION OF CAMPYLOBACTER-LARI ENTERITIS [J].

GOUDSWAARD, J ;

SABBE, L ;

WINKEL, WT .

JOURNAL OF INFECTION, 1995, 31 (02) :171-171

[7]

HOLT JG, 1994, BERGEYS MANUAL DETER, P58

[8] ROLE OF THE BETA-LACTAMASE OF CAMPYLOBACTER-JEJUNI IN RESISTANCE TO BETA-LACTAM AGENTS [J].

LACHANCE, N ;

GAUDREAU, C ;

LAMOTHE, F ;

LARIVIERE, LA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) :813-818

[9] SUSCEPTIBILITIES OF BETA-LACTAMASE-POSITIVE AND BETA-LACTAMASE-NEGATIVE STRAINS OF CAMPYLOBACTER-COLI TO BETA-LACTAM AGENTS [J].

LACHANCE, N ;

GAUDREAU, C ;

LAMOTHE, F ;

TURGEON, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1174-1176

[10] NEW, EXTENDED BIOTYPING SCHEME FOR CAMPYLOBACTER-JEJUNI, CAMPYLOBACTER-COLI, AND CAMPYLOBACTER-LARIDIS [J].

LIOR, H .

JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 20 (04) :636-640